GK Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$126K Sell
109
-108
-50% -$127K 0.07% 254
2026
Q2
$261K Buy
+217
New +$222K 0.14% 176
2026
Q1
– Sell
-246
Closed -$264K – 132
2025
Q4
$264K Sell
246
-42
-15% -$40.2K 0.18% 139
2025
Q3
$220K Sell
288
-127
-31% -$94.5K 0.16% 157
2025
Q2
$323K Sell
415
-106
-20% -$82.4K 0.29% 92
2025
Q1
$430K Buy
521
+68
+15% +$56.6K 0.49% 53
2024
Q4
$350K Buy
+453
New +$375K 0.44% 65

Other funds holding LLY

GK Wealth Management's LLY Position: Q3 2026 in Review

GK Wealth Management reduced its Eli Lilly (LLY) stake by 50% in Q3 2026, selling an estimated $127K and leaving 109 shares worth $126K. The position accounts for 0.07% of the portfolio, ranked #254.

GK Wealth Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $430K in Q1 2025. 1,387 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • GK Wealth Management held 109 shares of Eli Lilly worth $126K as of Q3 2026.
  • GK Wealth Management sold 108 Eli Lilly shares in Q3 2026, an estimated $127K.
  • Eli Lilly made up 0.07% of GK Wealth Management's portfolio in Q3 2026, its #254 holding.
  • GK Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • GK Wealth Management's Eli Lilly position peaked at $430K in Q1 2025.
  • 1,387 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.